Nelson Jen An Chao MD

PubMed

• Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transpl...
  Marie-Michèle Sainvil, Ashley L Artese, Laura J Fish, Chukwuamaka M Onyewadume, Joane Titus
  Transplantation and Cellular Therapy. 2025-09-19
• Optimized Monothiol Thioredoxin Derivative (ORP100S) Protects In Vitro and In Vivo from Radiation and Chemotoxicity Without Promoting Tumor Proliferation.
  Jian Wu, Xiaobei Wang, Parker Mathews, Shaima Jabbar, Min Zhang
  Advanced Science. 2025-09-11
• Trends in cell collection and apheresis practices: Insights from a cross-sectional study on the use of Spectra Optia in collection and transplant centers.
  Nabih Azar, Nelson J Chao, Manuel Cliquennois, Maria Geske, Tomoko Henzan
  Transfusion and Apheresis Science. 2025-09-02

Journal Articles

• Molecular composition of an antigen specific Ly-1 T suppressor inducer factor.  
  Yamaguchi H., Chao N. and Gershon R, Journal of Experimental Medicine. 155: 655-665, 1982
• Retroperitoneal fibrosis following treatment for Hodgkin's Disease.  
  Chao N., Levine J. and Horning S, Journal of Clinical Oncology 5:231-232, 1987
• A molecular basis for MHC class II - associated autoimmunity.  
  Todd J.A., Acha-Orbea H., Bell J.I., Chao N., Fronek Z., Jacob C.O., McDermott M., Sinha A., Timmerman L., Steinman L. and McDevitt H.O, Science 240:1003-1009, 1988
• Molecular characterization of class II (B1 domain) antigen in the BB diabetes prone and resistant rat.  
  Chao N., Jacob C., Timmerman, L. and McDevitt, H.O, Immunogenetics 29:231-234, 1989.
• Restoration of lymphokine activated killer cell activity after cryopreservation.  
  Schmidt-Wolf I, Aihara M, Negrin R, Blume KG and Chao NJ, Journal of Immunological Methods 125:185-189, 1989
• Allogeneic bone marrow transplantation: Part I.  
  Chao NJ and Blume KG, Western Journal of Medicine 151:638-663, 1989
• Allogeneic bone marrow transplantation: Part II.  
  Chao NJ and Blume KG, Western Journal of Medicine 152:46-51, 1990
• Assessment of purging with multidrug-resistance (MDR) modulators and etoposide (VP-16): Results of long-term marrow cultures.  
  Aihara M, Blume KG and Chao NJ, Experimental Hematology 18:940-944, 1990
• Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multiply drug-resistant human leukemic cell lines and normal bone marrow.  
  Chao NJ, Aihara M, Sikic BI and Blume KG, Experimental Hematology 18:1193, 1990
• Well-tolerated and effective treatment for patients with Hodgkin's lymphoma.  
  Chao NJ, Rosenberg S and Horning S. CEPP(B), Blood 76:1293-1298, 1990
• Bone marrow transplantation from histocompatible sibling donors for patients with acute lymphoblastic leukemia.  
  Blume KG, Schmidt GM, Chao NJ and Forman SJ, Hematology and Blood Transfusion 33:636-637, 1990
• Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplantation.  
  Chao NJ, Duncan SR, Long GD, Horning SJ, Blume KG, Annals of Internal Medicine 114:145-146, 1991
• A combined approach for purging multidrug resistant leukemia cell lines in bone marrow, using a monoclonal antibody and chemotherapy.  
  Aihara M, Aihara Y, Schmidt-Wolf G, Schmidt-Wolf I, Sikic BI, Blume KG and Chao NJ, Blood 77:2079-2084, 1991
• Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.  
  Forman SJ, Schmidt GM, Nademanee AP, Amylon MD, Chao NJ, Fahey JL, Konrad PN, Margolin KA, Niland JC, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Somlo G, Stein AS, ..., Journal of Clinical Oncology, 9:1570-1574, 1991
• Importance of bone marrow cytogenetic evaluation prior to autologous bone marrow transplantation for Hodgkin's disease.  
  Chao NJ, Nademanee AP, Long GD, Schmidt GM, Donlon TA, Parker P, Slovak ML, Nagasawa LS, Blume KG, and Forman SJ, Journal of Clinical Oncology, 9:1575-1579, 1991
• Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia during first complete remission.  
  Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Smith E, Wong RM, Hoppe RT, and Blume KG, Blood, 78:1923-1927, 1991
• The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin’s disease and non-Hodgkin’s lymphoma: pre...  
  Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Kwak LW, Long GD, Stallbaum B, O’Connor P, Blume KG, Annals of Oncology, Suppl 1:47-50, 1991
• Granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjunt to autologous hemopoietic stem cell transplantation for lymphoma.  
  Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, Fleming NC, Bonnem EM, and Greenberg PL, Annals of Internal Medicine, 116:183-189, 1992
• In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservation.  
  Schmidt-Wolf IGH, Aihara M, Negrin RS, Blume KG, and Chao NJ, Transfusion, 32:42-45, 1992
• Expression of Multidrug Resistance Gene mdr1 mRNA in a Subset of Normal Bone Marrow Cells.  
  Marie J-P, Brophy NA, Ehsan MN, Aihara Y, Mohamed NA, Cornbleet J, Chao NJ, and Sikic BI, British Journal of Hematology, 81:145-152
• Dynamic assessment of quality of life following autologous bone marrow transplantation.  
  Chao NJ, Tierney DK, Bloom JR, Long GD, Barr TA, Stallbaum B, Wong RM, Negrin RS, Horning SJ, and Blume KG, Blood, 80:825-830
• Use of etoposide in combination with cyclosporine for purging multidrug resistant leukemic cells from bone marrow in a mouse model.  
  Kuhl S-J, Sikic BI, Blume KG, and Chao NJ, Experimental Hematology, 20:1048-1054
• Busulfan/etoposide - Initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute non-lymphoblastic leukemia.  
  Chao NJ, Stein AS, Long GD, Negrin RS, Amylon MD, Wong RM, Forman SJ; Blume KG, Blood, 82:319-323
• G-CSF "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery following high dose chemotherapy.  
  Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, and Blume KG, Blood 81:2031-2035
• LAK activity against autologous lymphoma cells following bone marrow transplantation.  
  Schlegel PG, Schmidt-Wolf G, Schmidt-Wolf IGH, Kwak L, Blume KG, and Chao NJ, Cancer Research, Therapy and Control, 3:145-152
• Join now to see all

Books/Book Chapters

• High Dose Cancer Therapy: Pharmacology, Hematopoietins and Stem Cells. 
  Chapter: Reconstitution of hematopoiesis following allogeneic bone marrow transplantation 
  Chao NJ, and Blume KGEditors: Armitage, J.O., Antman, K.H.Williams and Wilkens, Baltimore, MD
• Thomas’ Hematopoietic Cell Transplantation. 
  Chapter: Pharmacological Prevention of Graft-vs-Host disease 
  Cavanagh HD, Colley AMEditors: Appelbaum F, Forman, S.J., Negrin RS. Blume, K.G.Blackwell Scientific Publications, Inc, New York
• Graft-vs.-Host Disease. 
  Chapter: Prophylaxis and Treatment of Acute Graft-vs.-Host Disease 
  Chao NJ, Holler E, Deeg HJEditors: Ferrara JLM, Cooke KR, Deeg HJ.Marcel Dekker Press, New York
• Stem Cell Transplatnation for Hematologic Malignancies. 
  Chapter: Umbilical Cord Hematopoietic Stem Cell Transplantation 
  Page 391 - 414Goggins T, Chao NJEditors: Soiffer R.Humana Press, Totowa NJ
• Hospital Medicine. 
  Chapter: Leukemia 
  Rizzieri DA, Long GD, Chao NJEditors: Wachter RM, Goldman L, Hollander H.Lippincott Williams & Wilkins, Philadelphia, PA
• Bone Marrow Transplantation. 
  Chapter: Pharmacological Prevention of Graft-vs-Host disease 
  Chao NJEditors: Forman, S.J., Thomas, E.D. Blume, K.G.Blackwell Scientific Publications, Inc, New York, NY
• Up to Date. 
  Chapter: Graft-versus-Host Disease 
  Chao NJEditors: Rose B.Wellesley, MA
• Textbook of Internal Medicine. 
  Chapter: Transplantation Immunology 
  Chao NJEditors: Kelley WN., J.B.Lippincott, New York, NY
• The Kidney in Liver Disease. 
  Chapter: Veno-occlusive Disease 
  Chao NJ, and Sackstein REditors: Epstein M.Elsevier, New York
• On Call in...Bone Marrow Transplantation. 
  Chapter: Prevention and treatment of graft-versus-host disease 
  Chao NJEditors: Burt RK, Deeg J, Santos G.. G. Landes, Austin, TX
• Graft-versus-Host Disease. 
  Chapter: vivo prevention and treatment of GVHD 
  Chao NJ and Deeg HJEditors: Ferrara, J.L.M., Deeg, H.J., and Burakoff S.Marcel Dekker, New York
• Graft-versus-Host Disease: Past, Present, and Future. 
  Chao NJRP Landes Company, Austin, TX
• Autologous Bone Marrow Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Multiple Myeloma. 
  Chapter: The Stanford experience with high-dose etoposide-containing regimens in intermediate and high-grade non-Hodgkin's lymphoma 
  Page 77 - 82Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Long GD, and Blume KGEditors: Zander, Barlogie.Springer-Verlag, New York, NY
• Bone Marrow Transplantation. 
  Chapter: Allogeneic Bone Marrow Transplantation for Acute Lymphoblastic Leukemia 
  Chao NJ and Forman SJEditors: Forman, S.J., Thomas, E.D. Blume, K.G.Blackwell Scientific Publications, Inc, New York
• Chemoradiation: an Integrated Approach in Oncology. 
  Chapter: Total body irradiation and chemotherapy for bone marrow transplantation 
  Chao NJ, Hoppe RT, Forman SJ, and Blume KGEditors: John, M.J., Flam, M.S., Legha, S.S. and Phillips, T.L.Lea & Febiger, Philadelphia
• Advances in Bone Marrow Purging and Processing. 
  Chapter: Use of etoposide in combination with cyclosporine for purging multidrug resistant leukemic cells from bone marrow in a mouse model 
  Page 25 - 34Kuhl J-S, Sikic BI, Blume KG, and Chao NJEditors: Gross, S. and Gee, A.P.Wiley-Liss, New York
• Advances in Bone Marrow Purging and Processing. 
  Chapter: Purging multidrug resistant cells from the bone marrow 
  Page 13 - 24Chao NJ, Aihara M, Kuhl J-S, Blume KG, and Sikic BIEditors: Gross, S. and Gee, A.P.Wiley-Liss, New York
• Medicine. 
  Chapter: Hematology/Oncology (Section VII) 
  Chao NJEditors: Fishman, M.C., Hoffman, A.R., Klausner, R.D., Thaler, M.S., J.B.Lippincott, Philadelphia, PA
• High Dose Cancer Therapy: Pharmacology, Hematopoietins and Stem Cells. 
  Chapter: Reconstitution of hematopoiesis following allogeneic bone marrow transplantation 
  Chao NJ, and Blume KGEditors: Armitage, J.O., Antman, K.H.Williams and Wilkens, Baltimore, MD
• Clinical Transplants. 
  Chapter: Bone Marrow Transplantation: the Stanford experience 
  Chao NJ, Long GD, Negrin RS, Horning SJ and Blume KGEditors: Terasaki, P.UCLA Tissue Typing Laboratory, Los Angeles, CA
• Acute Lymphoblastic Leukemia. 
  Chapter: Bone marrow transplantation acute lymphoblastic leukemia 
  Page 279 - 283Blume KG, Schmidt GM, Chao NJ, Amylon MD, Konrad PN and Forman SJEditors: R.P. Gale and D. Hoelzer.Wiley-Liss, New York
• Graft-versus-Host Disease. 
  Chao NJRP Landes Company, Austin, TXEdition 2,
• Join now to see all

Abstracts/Posters

• Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell Transplantation
  Nelson J. Chao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd
  Nelson J. Chao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...
  Nelson J. Chao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Daily Chlorhexidine Gluconate Bathing Reduces the Rate of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Stem Cell Transplantation
  Nelson J. Chao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Impact of Capacity Development Program on Outcomes for Pediatric Hematologic Malignancies in Tanzania
  Nelson J. Chao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host Disease
  Nelson J. Chao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Microrna-191 Regulates T-Cell Clonal Expansion during Graft-Versus-Host Disease
  Nelson J. Chao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Other

• Pathogenesis of graft-versus-host disease 
  Chao NJ
  http://www.uptodate.com/contents/pathogenesis-of-graft-versus-host-disease
  UpToDate, Wolters Kluwer Health - 2012-10-02
• Prevention and treatment of acute graft-versus-host disease: Recommendations 
  Chao NJ
  http://www.uptodate.com/contents/prevention-and-treatment-of-acute-graft-versus-host-disease-recomme
  UpToDate, Wolters Kluwer Health - 2012-09-18
• Prevention of acute graft-versus-host disease: Trials of T cell depletion 
  Chao NJ
  http://www.uptodate.com/contents/prevention-of-acute-graft-versus-host-disease-trials-of-t-cell-depl
  UpToDate, Wolters Kluwer Health - 2012-10-05
• Prevention of acute graft-versus-host disease: Trials of pharmacologic therapy 
  Chao NJ
  http://www.uptodate.com/contents/prevention-of-acute-graft-versus-host-disease-trials-of-pharmacolog
  UpToDate, Wolters Kluwer Health - 2012-09-18
• Treatment of acute graft-versus-host disease: Clinical trials 
  Chao NJ
  http://www.uptodate.com/contents/treatment-of-acute-graft-versus-host-disease-clinical-trials
  UpToDate, Wolters Kluwer Health - 2012-10-02
• Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens 
  Chao NJ
  http://www.uptodate.com/contents/umbilical-cord-blood-transplantation-in-adults-using-myeloablative-
  UpToDate, Wolters Kluwer Health - 2012-06-28
• Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease 
  Chao NJ
  http://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-grading-of-acute-graft-versus
  UpToDate, Wolters Kluwer Health - 2013-01-10
• Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease 
  Chao NJ
  http://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-grading-of-chronic-graft-vers
  UpToDate, Wolters Kluwer Health - 2013-01-02
• Overview of immunosuppressive agents used for prevention and treatment of graft-versus-host disease 
  Chao NJ
  http://www.uptodate.com/contents/overview-of-immunosuppressive-agents-used-for-prevention-and-treatm
  UpToDate, Wolters Kluwer Health - 2013-03-25
• Treatment of chronic graft-versus-host disease 
  Chao NJ
  http://www.uptodate.com/contents/treatment-of-chronic-graft-versus-host-disease
  UpToDate, Wolters Kluwer Health - 2013-01-07
• Selection of an umbilical cord blood graft for hematopoietic cell transplantation 
  Chao NJ
  http://www.uptodate.com/contents/selection-of-an-umbilical-cord-blood-graft-for-hematopoietic-cell-t
  UpToDate, Wolters Kluwer Health - 2013-03-15
• Join now to see all